BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Stemgent 

790 Memorial Drive
Suite 102
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-245-0000 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
Cellectis BioResearch and Stemgent Partner to Provide Custom Genome-Engineered iPS Cells 3/7/2013 10:06:25 AM    More...
Stemgent Completes Acquisition of Asterand plc (ATD.L)'s Human Tissue Business 8/1/2012 9:51:48 AM    More...
American Type Culture Collection and Stemgent Announce Collaborative Research Agreement to Advance Development of Novel Stem Cell Reagents and Pluripotent Cells 6/15/2011 7:06:49 AM    More...
Stemgent Finds $5.6 Million More 5/17/2010 7:21:23 AM    More...
Stemgent and Pfizer Inc. (PFE) Announce Collaboration 4/16/2010 11:10:07 AM    More...
Stemgent Betting $4.5 Million on Scottish Biotech 3/3/2010 7:47:23 AM    More...
Stemgent and Fate Therapeutics Launch Catalyst: A Unique Industry Program for First Access to the Most Advanced Induced Pluripotent Stem Cell Technology 4/24/2009 11:00:42 AM    More...
Fate Therapeutics and Stemgent Launch Catalyst: A Unique Industry Program for First Access to the Most Advanced Induced Pluripotent Stem Cell Technology 4/23/2009 11:04:22 AM    More...
Stemgent, CellDesign Sign Co-Exclusive Marketing Agreement on Stem Cell-Based Adipocyte Research Products 3/25/2009 9:24:30 AM    More...
Stemgent Raises $14 Million 3/10/2009 9:22:22 AM    More...

//-->